This review covers relevant clinical and laboratory information relating to Epstein-Barr virus (EBV)
infections in immunocompromised hosts. It describes the epidemiology and clinical …

… Epstein–Barr virus (EBV) was discovered in 1964 in cells … was immediate speculation that
the virus might be involved in … the viral genome and producing new viral particles in the viral …

… Epstein-Barr virus nuclear antigen … Epstein-Barr virus (EBV) is arguably the most ubiquitous
of human viruses, infecting at least 90% of adults worldwide [1]. It is also the first human …

… Our appreciation for the extent of Epstein Barr virus (EBV) transcriptome complexity continues
to grow through findings of EBV encoded microRNAs, new long non-coding RNAs as well …

… Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a … of EBV
viral proteins and non-coding RNAs contribute to EBV-mediated disease pathologies. The virus …

Epstein–Barr virus (EBV), originally discovered through its association with Burkitt lymphoma,
is now aetiologically linked to a remarkably wide range of lymphoproliferative lesions and …

… It is more than 50 years since the Epstein–Barr virus (EBV), the first human tumour virus, …
-year history of EBV and discusses how this virus provides a paradigm for exploiting insights at …

… Epstein–Barr virus (EBV) is a ubiquitous human lymphotropic … How a ubiquitous virus that
typically leads to benign latent … Epstein–Barr virus (EBV) was the first human tumour virus …

Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult population.
Primary EBV infection usually occurs during childhood and is generally asymptomatic, …

Epstein-Barr virus (EBV), also known as human herpesvirus 4, is a double-stranded DNA
virus that is ubiquitous in 90–95% of the population as a gamma herpesvirus. It exists in two …